Protox Therapeutics Inc. (TSX-V:PRX), a Canadian biotech company, announced that it will proceed with one of three scheduled Phase 2a clinical trials evaluating PRX302 for the treatment of localized recurrent prostate cancer. Protex has begun the process of patient screening for the trial. The Phase 2a study is designed to optimize dosing in order to [...]
Evidence indicates that excessive calcium intake may increase the risk of developing metastatic prostate cancer (advanced prostate cancer). A 1998 Harvard School of Public Health study of 47,781 men found those consuming between 1,500 and 1,999 mg of calcium per day had about double the risk of being diagnosed with metastatic prostate cancer as those [...]
I hate riding the NYC subway. Not because I think it's a dirty, crime infested mess (it's not). I mainly hate it because you never know who you're going to see. Sure, there may be the occasional homeless person funking up the train. But I'm not talking about that guy - he doesn't bother me. [...]
I am very lucky as I have a committed, loving, long-term marriage. I have been married to Wendy for a very happy 34 years. Together, and with her loving support, we have managed to work through the many negative side effects from my primary treatment as well as from the hormone blockade. The side effects [...]
Those of us in the prostate cancer world know that our disease presents us with many contradictions. Our dietary and suggested supplement recommendations seem to be modified as often as the wind changes direction. Even more serious is our lack of good tumor markers for disease progression. The result is we are forced to make [...]